KOBAYASHI PHARMACEUTICAL CO LTDKOBAYASHI PHARMACEUTICAL CO LTDKOBAYASHI PHARMACEUTICAL CO LTD

KOBAYASHI PHARMACEUTICAL CO LTD

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪2.78 B‬EUR
0.85EUR
‪130.59 M‬EUR
‪1.11 B‬EUR
‪42.18 M‬
Beta (1Y)
0.06
Employees (FY)
‪3.53 K‬
Change (1Y)
+39 +1.12%
Revenue / Employee (1Y)
‪347.84 K‬EUR
Net income / Employee (1Y)
‪40.79 K‬EUR

About KOBAYASHI PHARMACEUTICALS


Headquarters
Osaka
Founded
1886
ISIN
JP3301100008
FIGI
BBG000CBWVZ9
Kobayashi Pharmaceutical Co., Ltd. engages in the manufacture and sale of over-the-counter (OTC) pharmaceuticals, quasi-drugs, air fresheners, and sanitary products. It operates through the following segments: Domestic Business and International Business. The Domestic Business segment manufactures and sells health care products, daily necessities, skin care products, and body warmers in Japan. The International Business segment sells beauty and health care products overseas. . The company was founded by Chubei Kobayashi in February 1886 and is headquartered in Osaka, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of KOY is 36.60 EUR — it hasn't changed in the past 24 hours. Watch KOBAYASHI PHARMACEUTICAL CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange KOBAYASHI PHARMACEUTICAL CO LTD stocks are traded under the ticker KOY.
KOY stock has risen by 8.28% compared to the previous week, the month change is a 10.24% rise, over the last year KOBAYASHI PHARMACEUTICAL CO LTD has showed a −12.02% decrease.
We've gathered analysts' opinions on KOBAYASHI PHARMACEUTICAL CO LTD future price: according to them, KOY price has a max estimate of 43.27 EUR and a min estimate of 30.29 EUR. Watch KOY chart and read a more detailed KOBAYASHI PHARMACEUTICAL CO LTD stock forecast: see what analysts think of KOBAYASHI PHARMACEUTICAL CO LTD and suggest that you do with its stocks.
KOY reached its all-time high on Feb 1, 2021 with the price of 92.00 EUR, and its all-time low was 30.40 EUR and was reached on Mar 27, 2024. View more price dynamics on KOY chart.
See other stocks reaching their highest and lowest prices.
KOY stock is 0.00% volatile and has beta coefficient of 0.06. Track KOBAYASHI PHARMACEUTICAL CO LTD stock price on the chart and check out the list of the most volatile stocks — is KOBAYASHI PHARMACEUTICAL CO LTD there?
Today KOBAYASHI PHARMACEUTICAL CO LTD has the market capitalization of ‪2.78 B‬, it has increased by 7.55% over the last week.
Yes, you can track KOBAYASHI PHARMACEUTICAL CO LTD financials in yearly and quarterly reports right on TradingView.
KOBAYASHI PHARMACEUTICAL CO LTD is going to release the next earnings report on Jan 31, 2025. Keep track of upcoming events with our Earnings Calendar.
KOY earnings for the last quarter are 0.33 EUR per share, whereas the estimation was 0.51 EUR resulting in a −36.16% surprise. The estimated earnings for the next quarter are 0.49 EUR per share. See more details about KOBAYASHI PHARMACEUTICAL CO LTD earnings.
KOBAYASHI PHARMACEUTICAL CO LTD revenue for the last quarter amounts to ‪258.20 M‬ EUR, despite the estimated figure of ‪273.96 M‬ EUR. In the next quarter, revenue is expected to reach ‪328.38 M‬ EUR.
KOY net income for the last quarter is ‪24.42 M‬ EUR, while the quarter before that showed ‪2.67 M‬ EUR of net income which accounts for 815.55% change. Track more KOBAYASHI PHARMACEUTICAL CO LTD financial stats to get the full picture.
KOBAYASHI PHARMACEUTICAL CO LTD dividend yield was 1.49% in 2023, and payout ratio reached 37.66%. The year before the numbers were 1.00% and 34.67% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 28, 2024, the company has ‪3.53 K‬ employees. See our rating of the largest employees — is KOBAYASHI PHARMACEUTICAL CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KOBAYASHI PHARMACEUTICAL CO LTD EBITDA is ‪194.07 M‬ EUR, and current EBITDA margin is 18.36%. See more stats in KOBAYASHI PHARMACEUTICAL CO LTD financial statements.
Like other stocks, KOY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KOBAYASHI PHARMACEUTICAL CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KOBAYASHI PHARMACEUTICAL CO LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KOBAYASHI PHARMACEUTICAL CO LTD stock shows the buy signal. See more of KOBAYASHI PHARMACEUTICAL CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.